Instem upbeat after solid year
Chief executive Phil Reason told investors: "With increasing momentum in the business from recent contract wins and the growing pipeline, we are confident about the outlook for the Group for 2019 and beyond."
Company
LON:INS
Instem PLC is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for study management, regulatory submissions, clinical trial acceleration, and informatics-based insight generation. The company's solutions are in use by over 700 customers worldwide, including all of the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster.
109 stories · page 2 of 6
Chief executive Phil Reason told investors: "With increasing momentum in the business from recent contract wins and the growing pipeline, we are confident about the outlook for the Group for 2019 and beyond."
Archive
Aside from the UK and US data - and Brexit - corporate news in the week ahead will include updates from blue-chip budget airline easyjet and Ladbrokes Coral owner GVC Holdings
Lowther’s first foray into the pharma and biotech sector was with US giant Monsanto, after which she has gone on to work for smaller industry players such as Novacyt, BioWisdom and, more recently, IXICO
In a trading update posted in July, Instem said revenue rose 10% in the first half of 2019 as all three areas of its business performed well.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including IGas Energy, Egdon Resources, Mobile Streams, GYG Group, Dillistone, Connect Group and Non-Standard Finance
Instem said all three areas of the business - data collection, regulatory solutions and informatics – made “positive contributions” as it reported that profit margins had strengthened
Archive
Top laggard on Footsie was oil services giant Wood Group, which shed 4.09% to 524.80p
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's movers and shakers, featuring N4 Pharma, Zin Media, Rurelec, Trinity Exploration, Hurricane Energy, Thomas Cook, Gama Aviation, CyanConnode and Mosman
Instem generated revenues of £10.5mln (H1 17: £10.3mln) in the opening six months of 2018, reporting a profit before tax of £0.1mln (H1 17: loss of £0.6mln)
The UK blue-chip index lost almost 32 points at 7,458
A look at some of the biggest risers and fallers in London on Monday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The company has developed software used by the life sciences industry to collate and transmit data
Archive
In London, FTSE 100 shed 23 points to 7,655, while FTSE 250 shed over 155 points at 20,770
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London on Wednesday